NINLARO (ixazomib) Presentation
Continuous Proteasome Inhibition with NINLARO (ixazomib) Offers Durable Efficacy and Management Tolerability for the Types of Patients You See Every Day Speaker: Rajesh Behl, MD Medical Director Alta Bates Summit Comprehensive Cancer Center RSVP by 11/11: Fax: 866-360-5729 |
|